These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38133666)

  • 1. Immunotherapy in rectal cancer patients-a propensity score matched analysis of the National Cancer Database.
    Horesh N; Emile SH; Freund MR; Garoufalia Z; Gefen R; Nagarajan A; Wexner SD
    Int J Colorectal Dis; 2023 Dec; 39(1):8. PubMed ID: 38133666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy in Stage III-IV Colon Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
    Horesh N; Emile SH; Garoufalia Z; Gefen R; Zhou P; Nagarajan A; Wexner SD
    J Immunother; 2024 Oct; 47(8):342-350. PubMed ID: 38638079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of primary tumor radiotherapy in patients with Unresectable stage IV Rectal or Rectosigmoid Cancer: a propensity score matching analysis for survival.
    Wang G; Wang W; Jin H; Dong H; Chen W; Li X; Li G; Li L
    Radiat Oncol; 2020 May; 15(1):126. PubMed ID: 32460810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I-II or unresected stage III pancreatic cancer.
    Ma SJ; Iovoli AJ; Hermann GM; Prezzano KM; Singh AK
    Cancer Med; 2019 Aug; 8(9):4110-4123. PubMed ID: 31183965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of the Microsatellite Instability Status in Patients With Stage II/III Rectal Cancer Following Upfront Surgery.
    Oh CR; Kim JE; Kang J; Kim SY; Kim KP; Hong YS; Lim SB; Yu CS; Kim JC; Kim J; Jang SJ; Kim TW
    Clin Colorectal Cancer; 2018 Dec; 17(4):e679-e685. PubMed ID: 30077598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Impact of Microsatellite Instability on the Outcome of Appendiceal Adenocarcinoma: a National Cancer Database Analysis.
    Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Wexner SD
    J Gastrointest Surg; 2023 Feb; 27(2):354-362. PubMed ID: 36650414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Relevance of Mucinous Subtype in a Population-based Propensity Score Analysis of 40,083 Rectal Cancer Patients.
    Tarantino I; Hüttner FJ; Warschkow R; Schmied BM; Diener MK; Ulrich A
    Ann Surg Oncol; 2016 May; 23(5):1576-86. PubMed ID: 26714956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the Characteristics, Treatment, and Outcomes of Rectal Adenocarcinoma in the US From 2004 to 2019: A National Cancer Database Analysis.
    Emile SH; Horesh N; Freund MR; Garoufalia Z; Gefen R; Silva-Alvarenga E; Maron DJ; DaSilva G; Wexner SD
    JAMA Oncol; 2023 Mar; 9(3):355-364. PubMed ID: 36580307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncologic outcomes for low rectal adenocarcinoma following low anterior resection with coloanal anastomosis versus abdominoperineal resection: a National Cancer Database propensity matched analysis.
    Fields AC; Scully RE; Saadat LV; Lu P; Davids JS; Bleday R; Goldberg JE; Melnitchouk N
    Int J Colorectal Dis; 2019 May; 34(5):843-848. PubMed ID: 30790033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No benefit after neoadjuvant chemoradiation in stage IV rectal cancer: A propensity score-matched analysis on a real-world population.
    Milito P; Sorrentino L; Pietrantonio F; Di Russo A; Citterio D; Mazzaferro V; Cosimelli M
    Dig Liver Dis; 2021 Aug; 53(8):1041-1047. PubMed ID: 33487580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival.
    Wakeam E; Acuna SA; Leighl NB; Giuliani ME; Finlayson SRG; Varghese TK; Darling GE
    Lung Cancer; 2017 Jul; 109():78-88. PubMed ID: 28577955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival Outcomes After Surgical Management of the Primary Tumor With and Without Radiotherapy for Metastatic Rectal Adenocarcinoma: A National Cancer Database (NCDB) Analysis.
    Renz P; Wegner RE; Hasan S; Brookover R; Finley G; Monga D; Raj M; McCormick J; Kirichenko A
    Clin Colorectal Cancer; 2019 Jun; 18(2):e237-e243. PubMed ID: 30905549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis.
    Renehan AG; Malcomson L; Emsley R; Gollins S; Maw A; Myint AS; Rooney PS; Susnerwala S; Blower A; Saunders MP; Wilson MS; Scott N; O'Dwyer ST
    Lancet Oncol; 2016 Feb; 17(2):174-183. PubMed ID: 26705854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
    Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
    Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival benefit from immunocheckpoint inhibitors in stage IV non-small cell lung cancer patients with brain metastases: A National Cancer Database propensity-matched analysis.
    Takamori S; Komiya T; Powell E
    Cancer Med; 2021 Feb; 10(3):923-932. PubMed ID: 33340271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentre propensity score-matched analysis of laparoscopic versus open surgery for T4 rectal cancer.
    de'Angelis N; Landi F; Vitali GC; Memeo R; Martínez-Pérez A; Solis A; Assalino M; Vallribera F; Mercoli HA; Marescaux J; Mutter D; Ris F; Espin E; Brunetti F
    Surg Endosc; 2017 Aug; 31(8):3106-3121. PubMed ID: 27826780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis.
    Ecker BL; McMillan MT; Datta J; Mamtani R; Giantonio BJ; Dempsey DT; Fraker DL; Drebin JA; Karakousis GC; Roses RE
    Cancer; 2016 Mar; 122(5):693-701. PubMed ID: 26717303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of overall survival and cancer-specific survival in patients with resected early-stage rectal adenocarcinoma: a SEER-based study.
    Lee KC; Chung KC; Chen HH; Liu CC; Lu CC
    J Investig Med; 2017 Dec; 65(8):1148-1154. PubMed ID: 28735257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
    Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
    JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.